Argüello D Fermín, Tomashek Kay M, Quiñones Luz, Beltran Manuela, Acosta Luz, Santiago Luis M, Biggerstaff Brad J, Garcia-Rivera Enid J, Sun Wellington, Pollissard-Gadroy Laurence, Luxemburger Christine, Hunsperger Elizabeth
National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector-Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico; Office of the Director, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado; University of Puerto Rico School of Medicine, San Juan, Puerto Rico; Food and Drug Administration, Silver Spring, Maryland; Sanofi Aventis, Paris, France; Sanofi Pasteur, Lyon, France.
National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector-Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico; Office of the Director, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado; University of Puerto Rico School of Medicine, San Juan, Puerto Rico; Food and Drug Administration, Silver Spring, Maryland; Sanofi Aventis, Paris, France; Sanofi Pasteur, Lyon, France
Am J Trop Med Hyg. 2015 Mar;92(3):486-91. doi: 10.4269/ajtmh.14-0231. Epub 2015 Feb 2.
Dengue is a potentially fatal acute febrile illness caused by the mosquito-borne dengue viruses (DENV-1 to -4). To estimate DENV seroincidence in school-aged children, a 1-year prospective cohort study was conducted in Patillas, Puerto Rico; 10- to 18-year-olds (N = 345) were randomly selected from 13 public schools. At enrollment, 49.8% of the entire cohort had DENV immunoglobulin G (IgG) anti-DENV antibodies, and there were individuals with neutralizing antibodies specific to each of the four DENV. The mean age of participants with incident DENV infection was 13.4 years. The 1-year seroincidence rate was 5.6%, and 61.1% of infections were inapparent. Having IgG anti-DENV at enrollment was associated with seroincidence (risk ratio = 6.8). Acute febrile illnesses during the study period were captured by a fever diary and an enhanced and passive surveillance system in the municipios of Patillas and Guayama. In summary, at enrollment, nearly one-half of the participants had a prior DENV infection, with the highest incidence in the 10- to 11-year-olds, of which most were inapparent infections, and symptomatic infections were considered mild.
登革热是一种由蚊子传播的登革病毒(DENV-1至-4)引起的潜在致命性急性发热疾病。为了估计学龄儿童中的登革病毒血清感染率,在波多黎各的帕蒂亚斯进行了一项为期1年的前瞻性队列研究;从13所公立学校中随机选取了10至18岁的儿童(N = 345)。在入组时,整个队列中有49.8%的人具有登革病毒免疫球蛋白G(IgG)抗登革病毒抗体,并且存在针对四种登革病毒中每一种的具有中和抗体的个体。发生登革病毒感染的参与者的平均年龄为13.4岁。1年血清感染率为5.6%,61.1%的感染为隐性感染。入组时具有抗登革病毒IgG与血清感染率相关(风险比 = 6.8)。研究期间的急性发热疾病通过发热日记以及帕蒂亚斯和瓜亚马市的强化被动监测系统进行记录。总之,入组时,近一半的参与者曾有过登革病毒感染,其中10至11岁的儿童感染率最高,大多数为隐性感染,有症状的感染被认为是轻度的。